Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00070070Phase 1Completed
Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas
Transitional Cell Carcinoma
PrincipalinvestigatorStart date: 2003-10-28

Research Network

Collaboration Network

3 collaborators·2 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Memorial Sloan Kettering Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dean F. Bajorin, MD

Memorial Sloan Kettering Cancer Center

Related
8 trials

Shared therapeutic areas:

Urinary Bladder CancerCarcinoma, Transitional Cell

Worked with same sponsors:

Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer Center+1 more
Collaborated on 1 trial
Similarity Score24%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score10%

Jitendra Amlani, MD

Urocare Hospital

Related
2 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score10%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

Related
12 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score10%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Urinary Bladder Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Andrea B Apolo, M.D.

National Cancer Institute (NCI)

Related
12 trials

Shared therapeutic areas:

Urinary Bladder Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Sushil Bhatia, MD

Choithram Hospital and Research Centre

Related
2 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score10%

Yoshiya Yamada, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Urinary Bladder Cancer

Worked with same sponsors:

Memorial Sloan Kettering Cancer Center
Similarity Score10%

Laurence H. Klotz, MD

Toronto Sunnybrook Regional Cancer Centre

Related
5 trials

Shared therapeutic areas:

Urinary Bladder Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Ali Kaan Yildiz

Ankara Training and Resarch Hospital

Related
9 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02281383Phase 2PrincipalInvestigator

Evaluate the Response to 2 Induction Courses (12 Intravesical Instillations) of Bacillus Calmette-Guérin (BCG) for High Risk Superficial Bladder Cancer

Bladder CancerHigh Risk Superficial
Completed
NCT00070070Phase 1PrincipalInvestigator

Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas

Transitional Cell Carcinoma
Completed

All 2 trials loaded